Eugen Steiner
Chairman en BIOARCTIC AB .
Fortuna: 8 M $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 25 años |
Pär Lars Gellerfors | M | 77 | 21 años | |
Cecilia Marie Edström | F | 58 |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | 1 años |
Anki Forsberg | F | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 25 años |
Carl-Johan Spak | M | 68 |
Karolinska Institutet
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest.
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 13 años |
Åke Mikael Smedeby | M | 56 | 6 años | |
Oskar Bosson | M | 48 | 4 años | |
Jan Mattsson | M | 64 | 7 años | |
Bengt Håkan Englund | M | 72 | 4 años | |
Annika Andersson | F | 66 |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Nicklas Westerholm | M | 48 | 5 años | |
Elin Kristina Ekberg | F | 46 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 3 años |
Lennart Rolf Ivar Verner | M | 77 | 14 años | |
Charlotta Ljungqvist | M | 63 | 3 años | |
Clive Page | M | 66 |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | - |
Gunilla Christina Osswald | M | 63 | 11 años | |
Georg Beiske | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 5 años |
Björn Ingemar Odlander | M | 66 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 28 años |
Finnur Einarsson | M | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 10 años |
Fridrik Gardarsson | M | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 10 años |
CARL KILANDER | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 5 años |
Alex Valcu | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 20 años |
Johan Rutger Christenson | M | 65 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
Karolinska Institutet
| 38 años |
Paul Hargreaves | M | 55 | 3 años | |
Robert Helgason | M | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 3 años |
Tobias Alfvén | M | - |
Stiftelsen Forskasverige
| - |
Göran Lerenius | M | 74 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | - |
Magnus Berg Magnusson | M | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 10 años |
Ivar Guoejonsson | M | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | - |
Christian Krog Jensen | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Milan Zdravkovic | M | 54 |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | 4 años |
Anna-Kaija Grönblad | F | 56 | 3 años | |
Gunilla Andersson | F | 63 | 5 años | |
Christian Krog-Jensen | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Karin Dahlman-Wright | F | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Arvid Söderhäll | M | - |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | - |
Åsa Kallas | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Hans Möller | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Johanna Fälting | M | 52 | 12 años | |
Anne Bloch Thomsen | M | - |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | - |
Bengt Ingemar Samuelsson | M | 90 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | - |
Mats Ferm | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Lilian Birgitta Wikström | M | 63 |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | 14 años |
Hugh Young Rienhoff | M | 71 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | - |
Carl Erik Mathias Uhlén | M | 70 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | - |
Thomas Halvorsen | M | 75 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | - |
Hilmar Bragi Janusson | M | 63 |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | - |
Hans Lennart Rudolf Wigzell | M | 86 |
Stockholm School of Entrepreneurship
| - |
Thor Jespersen | M | - |
Vir A/S
Vir A/S Medical SpecialtiesHealth Technology Vir A/S designs and manufactures biosensors. The firm's products are used in proteomics, genomics, drug discovery and development, forensics, food & feed analysis, biowarfare agent detection and environment analyses. The company is headquartered in Taastrup, Denmark. | - |
Jesper Jespersen | M | 78 |
Vir A/S
Vir A/S Medical SpecialtiesHealth Technology Vir A/S designs and manufactures biosensors. The firm's products are used in proteomics, genomics, drug discovery and development, forensics, food & feed analysis, biowarfare agent detection and environment analyses. The company is headquartered in Taastrup, Denmark. | - |
Carl-Johan Dalsgaard | M | 68 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 24 años |
Staffan Lindstrand | M | 62 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 27 años |
Per Anders Göte Samuelsson | M | 63 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 24 años |
Bror Thomas Pollare | M | 71 |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | - |
Peder Fredrikson | M | - |
Vir A/S
Vir A/S Medical SpecialtiesHealth Technology Vir A/S designs and manufactures biosensors. The firm's products are used in proteomics, genomics, drug discovery and development, forensics, food & feed analysis, biowarfare agent detection and environment analyses. The company is headquartered in Taastrup, Denmark. | - |
Patrik Blomquist | M | - |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | - |
Stig Hojberg-Jensen | M | - |
Vir A/S
Vir A/S Medical SpecialtiesHealth Technology Vir A/S designs and manufactures biosensors. The firm's products are used in proteomics, genomics, drug discovery and development, forensics, food & feed analysis, biowarfare agent detection and environment analyses. The company is headquartered in Taastrup, Denmark. | - |
Stefán Pétursson | M | 61 |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 2 años |
Lajos Gunnar Németh | M | 72 |
Stiftelsen Forskasverige
| 10 años |
Hans Arwidsson | M | 66 | 1 años | |
Christer Möller | M | 65 | 18 años | |
Anders Martin-Löf | M | 53 | 1 años | |
Alan Henry Raffensperger | M | 64 | 1 años | |
Marten Steen | M | 49 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 14 años |
Oern Stuge | M | 70 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 15 años |
Maria Bech | F | 56 |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | 3 años |
Tomas Odergren | M | 65 | 5 años | |
Max Odlander | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
John Hamill | M | 60 | 3 años | |
Pierre Legault | M | 63 | 4 años | |
Wenche Nelly A. Rolfsen Sandsborg | M | 72 | 7 años | |
Bob R. Seltzer | M | 48 | - | |
Christina Astrén Eriksson | F | 65 | - | |
Jonas Karl Hansson | M | 50 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 14 años |
Peter Leander | M | 67 | 11 años | |
Rhonda L. Stanley | F | 64 | 1 años | |
Robert Peterson | M | 67 | - | |
Mark A. Klausner | M | 71 | 4 años | |
Marco Taglietti | M | 64 | 3 años | |
Sten Nilsson | M | 76 | 10 años | |
Richard Åhlberg | M | - |
Karolinska Institutet
| 12 años |
James Mitchum | M | 71 | 4 años | |
Hans Christian Ekelund | M | 76 | 7 años | |
Richard Markham | M | 73 | 10 años | |
Alf E. A. Lindberg | M | 85 |
Karolinska Institutet
| 10 años |
Dan Cabo | M | - | 7 años | |
Lars Gösta Jonsson | M | 83 |
Karolinska Institutet
| 19 años |
Vidar Wendel-Hansen | M | 65 |
Karolinska Institutet
| 4 años |
Mats Norman | M | 61 |
Karolinska Institutet
| 4 años |
Carl Harald Janson | M | 66 |
Karolinska Institutet
| 3 años |
Sven Håkan Björklund | M | 68 |
Karolinska Institutet
| 5 años |
Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 3 años |
Kerstin Uvnäs Moberg | M | 80 |
Karolinska Institutet
| 3 años |
Donald Jones | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 2 años |
Christine Lind | F | 50 | - | |
Jaikrishna Patel | M | - | 1 años | |
Christer Nordstedt | M | 62 |
Karolinska Institutet
| 5 años |
Desiree Luthman | M | 65 |
Karolinska Institutet
| 3 años |
Martin Vogelbaum | M | 60 | 1 años | |
Alan Wells | M | - |
Karolinska Institutet
| 3 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Suecia | 75 | 75.00% |
Estados Unidos | 12 | 12.00% |
Islandia | 10 | 10.00% |
Dinamarca | 4 | 4.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Eugen Steiner
- Red Personal